May 7 (Reuters) - Biopharmaceutical company Odyssey ⁠Therapeutics ⁠has raised $279 million in ⁠its upsized U.S. initial ...

The expanded agreement extends and broadens the companies’ multi-year collaboration in oncology through 2027, according to ...

It’s a well-known and almost quaint fact that the human body is capable of regeneration. When we suffer a minor scrape or a ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 by 9 percentage ...

By Marleen Kaesebier BASEL, Switzerland, May 5 (Reuters) - Switzerland's biotech industry shifted toward private financing in 2025 as funding from capital markets remained difficult to obtain and ...

Only seven months after its last major round of Bay Area layoffs, biotech company Gilead Sciences is laying off 108 workers ...

Krystal Biotech delivered strong Q1 2026 results, with Vyjuvek sales up 32% YoY to $116.4M and gross margin expanding to 95%.

The biggest biotech deal so far in 2026 was announced in April. Pacts were signed over ADCs, small molecules, and AI ...

RoVa Labs, a $26 million biotech incubator in Roanoke, offers wet lab space and aims to create 250 jobs, strengthening the ...